IRCT20190119042410N1已完成3 期
The comparison of the Efficacy and Safety of Combination of Tamsulosin with Tolterodin and Tamsulosin alone In the Treatment of Double-J Stent Related Urinary Tract Symptoms
Boushehr University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- Male
入选标准
- •Patients over 18 years of age
- •Completion of written consent form
- •One-way ureteral stenting after ureteroscopy and TUL for ureteral stones
- •Negative urine culture prior to TUL and stents
排除标准
- •Physician diagnosed sensitivity to tamsulosin, toltrodine or folic acid
- •Establishment of ureteral stent during the last 6 months
研究者
相似试验
已完成
2 期
A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel with MORAb-004 in Metastatic Soft Tissue Sarcomasoft tissue cancer10072990NL-OMON39691Morphotek, Inc10
进行中（未招募）
1 期
A clinical trial that is evaluating how safe and effective an experimental treatment called MORAb-004 is when used in combination with Gemcitabine and Docetaxel in patients diagnosed with Metastatic Soft Tissue Sarcoma.EUCTR2012-001399-12-NLMorphotek Inc.200
进行中（未招募）
1 期
A clinical trial that is evaluating how safe and effective an experimental treatment called MORAb-004 is when used in combination with Gemcitabine and Docetaxel in patients diagnosed with Metastatic Soft Tissue Sarcoma.Metastatic Soft Tissue SarcomaMedDRA version: 15.1Level: HLGTClassification code 10041299Term: Soft tissue sarcomasSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-001399-12-BEMorphotek Inc.200
已完成
4 期
Comparison of single drug (rosuvastatin 40 mg)versus two drugs (rosuvastatin 20 mg and fenofibrate 145 mg) for the management of mixed dyslipidemia in patients with coronary artery disease.CTRI/2017/01/007633INDIRA GANDHI MEDICAL COLLEGE165
尚未招募
4 期
A study to assess the effectiveness and safety of Combination of Omega-3 Fatty Acids and Vitamin E versus Combined Oral Contraceptive Pills in Polycystic Ovarian SyndromeCTRI/2024/04/066435Pandit B. D. Sharma UHS Rohtak